Yvonne Greenstreet
Director, Chief Executive Officer · 5 filings · Latest: Sep 19, 2026
ALNYLAM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALNY | Yvonne Greenstreet | Director, Chief Executive Officer | Mar 4, 2026 | Sale | $323.08 | 2,933 | $947.6K | 95,695 | |
ALNY | Yvonne Greenstreet | Director, Chief Executive Officer | Mar 2, 2026 | Sale | $327.65 | 6,799 | $2.2M | 98,628 | |
ALNY | Yvonne Greenstreet | Director, Chief Executive Officer | Feb 27, 2026 | Option Exercise | $0.00 | 5,921 | — | 91,583 | |
ALNY | Yvonne Greenstreet | Director, Chief Executive Officer | Feb 13, 2026 | Sale | $310.08 | 6,958 | $2.2M | 85,662 | |
ALNY | Greenstreet Yvonne | — | Nov 12, 2025 | Proposed Sale | $453.10 | 25,650 | $11.6M | — | |
ALNY | Greenstreet Yvonne | — | Jun 2, 2025 | Proposed Sale | $303.10 | 19,297 | $5.8M | — | |
ALNY | Greenstreet Yvonne | — | May 30, 2025 | Proposed Sale | $304.39 | 31,640 | $9.6M | — |